FDA
-
-
-
-
-
-
-
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis
-
-
327,015 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

